Login to Your Account

Wuxi returns home and goes private for $3.3B

By Shannon Ellis
Staff Writer

Monday, December 14, 2015

SHANGHAI – Wuxi Pharmatech (Cayman) Inc., a new breed of contract R&D organization, has completed the privatization process, requesting its stocks to stop trading on the New York Stock Exchange on Dec. 10.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription